hematopoietic system
• early megakaryocyte maturation is blocked and proplatelet formation in culture is rare
|
Allele Symbol Allele Name Allele ID |
Gata1tm2.1Sho targeted mutation 2.1, Stuart Orkin MGI:2177587 |
||||||||||||||||
Summary |
3 genotypes
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• early megakaryocyte maturation is blocked and proplatelet formation in culture is rare
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• large increase in megakaryocytes in hematopoietic tissues, presumably because of mosaicism resulting from random X inactivation
• however, normal numbers of platelets
|
• proliferation of megakaryocyte progenitors is greatly enhanced in fetal livers, presumably because of mosaicism resulting from random X inactivation
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
N |
• mutants do not develop anemia and exhibit almost normal viability
|
• megakaryocytes are smaller than normal, have scant cytoplasm and condensed nuclei
|
• maturation of megakaryocytes is arrested
|
• 10-fold increase in megakaryocytes in the spleen and bone marrow
• excess of abnormal megakaryocytes in the yolk sac and early fetal liver
|
• proliferation of megakaryocyte progenitors is greatly enhanced in fetal livers
|
• platelet numbers are reduced to about 15% of normal
|
• maturation of megakaryocytes is arrested
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|